Sidney M. Hecht

Sidney M. Hecht

Auto-generated profile, based on publicly available information

Sidney M. Hecht

Arizona State University

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 1999 in Journal of Natural Products
Verified
Journal Article
Closed access
SHSidney M. Hecht
Sidney M. Hecht

13 February 2013 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ZYZhiqiang Yu
Zhiqiang Yu
RSRyan M. Schmaltz
Ryan M. Schmaltz
TBTrevor C. Bozeman
Trevor C. Bozeman
RPRakesh Paul
Rakesh Paul
MRMichael J. Rishel
Michael J. Rishel
SHSidney M. Hecht
Sidney M. Hecht

7 September 2016 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ACArnaud Chevalier
Arnaud Chevalier
Yanmin ZhangYanmin Zhang
Yanmin Zhang
OKOmar M. Khdour
Omar M. Khdour
JKJustin B. Kaye
Justin B. Kaye
SHSidney M. Hecht
Sidney M. Hecht

14 April 2004 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
JMJi Ma
Ji Ma
SHSidney M. Hecht
Sidney M. Hecht
Bioassay-guided fractionation of an extract prepared from Alangium javanicum using an assay to monitor Cu2+-dependent DNA strand scission led to the isolation of javaniside, a new type of oxindole glycoside.

3 September 2014 in Journal of the American Chemical Society
Verified
Journal Article
Open access
BSBenjamin R. Schroeder
Benjamin R. Schroeder
MGM. Imran Ghare
M. Imran Ghare
CBChandrabali Bhattacharya
Chandrabali Bhattacharya
RPRakesh Paul
Rakesh Paul
ZYZhiqiang Yu
Zhiqiang Yu
SHSidney M. Hecht
Sidney M. Hecht
The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon (deglycobleomycin) mediates DNA cleavage in much the same fashion as bleomycin, it exhibits diminished cytotoxicity in comparison to BLM. These findings suggested that BLM might be modular in nature, composed of tumor-seeking and tumoricidal domains. To explore this possibility, BLM analogues were prepared in which the disaccharide moiety was attached to deglycobleomycin at novel positions, namely, via the threonine moiety or C-terminal substituent. The analogues were compared with BLM and deglycoBLM for DNA cleavage, cancer cell uptake, and cytotoxic activity. BLM is more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the disaccharide on threonine was less active than deglycoBLM and the analogue containing the C-terminal disaccharide was slightly more potent. While having unexceptional DNA cleavage potencies, both glycosylated analogues were more cytotoxic to cultured DU145 prostate cancer cells than deglycoBLM. Dye-labeled conjugates of the cytotoxic BLM aglycons were used in imaging experiments to determine the extent of cell uptake. The rank order of internalization efficiencies was the same as their order of cytotoxicities toward DU145 cells. These findings establish a role for the BLM disaccharide in tumor targeting/uptake and suggest that the disaccharide moiety may be capable of delivering other cytotoxins to cancer cells. While the mechanism responsible for uptake of the BLM disaccharide selectively by tumor cells has not yet been established, data are presented which suggest that the metabolic shift to glycolysis in cancer cells may provide the vehicle for selective internalization.

9 February 2009 in Journal of Natural Products
Verified
Journal Article
Closed access
QKQasim A. Khan
Qasim A. Khan
JLJun Lu
Jun Lu
SHSidney M. Hecht
Sidney M. Hecht